ATE288743T1 - Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist - Google Patents

Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist

Info

Publication number
ATE288743T1
ATE288743T1 AT99922753T AT99922753T ATE288743T1 AT E288743 T1 ATE288743 T1 AT E288743T1 AT 99922753 T AT99922753 T AT 99922753T AT 99922753 T AT99922753 T AT 99922753T AT E288743 T1 ATE288743 T1 AT E288743T1
Authority
AT
Austria
Prior art keywords
administration
active ingredients
device suitable
pharmaceutical carrier
carrier device
Prior art date
Application number
AT99922753T
Other languages
English (en)
Inventor
Gilles H Tapolsky
David W Osborne
Original Assignee
Virotex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virotex Corp filed Critical Virotex Corp
Application granted granted Critical
Publication of ATE288743T1 publication Critical patent/ATE288743T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vending Machines For Individual Products (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99922753T 1998-04-29 1999-04-29 Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist ATE288743T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6970398A 1998-04-29 1998-04-29
PCT/US1999/009378 WO1999055312A2 (en) 1998-04-29 1999-04-29 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces

Publications (1)

Publication Number Publication Date
ATE288743T1 true ATE288743T1 (de) 2005-02-15

Family

ID=22090679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922753T ATE288743T1 (de) 1998-04-29 1999-04-29 Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist

Country Status (11)

Country Link
US (1) US20080254105A1 (de)
EP (1) EP1079813B1 (de)
JP (3) JP2002512950A (de)
AT (1) ATE288743T1 (de)
AU (1) AU746339B2 (de)
CA (1) CA2329128C (de)
DE (1) DE69923675T2 (de)
DK (1) DK1079813T3 (de)
ES (1) ES2237104T3 (de)
PT (1) PT1079813E (de)
WO (1) WO1999055312A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2003520191A (ja) * 1998-09-08 2003-07-02 ワトソン ファーマシューティカルズ， インコーポレイテッド 薬物の親水性塩類を含有する感圧接着剤マトリックスパッチの製造方法
DE19954421A1 (de) * 1999-11-12 2001-05-31 Lohmann Therapie Syst Lts Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
RU2276998C2 (ru) 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
DE10252726B4 (de) * 2002-11-13 2008-05-08 Lts Lohmann Therapie-Systeme Ag Mehrschichtiges transmucosales therapeutisches System
IL153124A (en) 2002-11-27 2010-06-30 Herbal Synthesis Corp Solid composition that can be glued to the lining
US7276246B2 (en) 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) * 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
CA2535846A1 (en) * 2003-08-15 2005-02-24 Qlt Usa, Inc. Adhesive bioerodible transmucosal drug delivery system
DE10358748A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform basierend auf vernetzten hydrophilen Polymeren
EP1713450B1 (de) 2004-01-30 2021-10-06 Corium, Inc. Schnell auflösender film zur abgabe eines wirkstoffs
WO2005090461A2 (en) * 2004-03-19 2005-09-29 The Tapemark Company Thermoplastic films and methods for making
BRPI0707367A2 (pt) * 2006-02-02 2011-05-03 Leo Pharma As composição farmacêutica, uso de uma composição, e, método de prevenir ou tratar uma doença dérmica ou condição da pele ou mucosa
AU2007275581B2 (en) 2006-07-21 2011-09-08 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US20080292683A1 (en) * 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
EP2008651A1 (de) * 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
JP2011507665A (ja) 2007-12-31 2011-03-10 アクラレント インコーポレイテッド 粘膜組織包帯剤及び使用方法
JP2011526256A (ja) * 2008-06-30 2011-10-06 コロプラスト アクティーゼルスカブ 口内炎用パッチ
JP5284070B2 (ja) * 2008-12-12 2013-09-11 救急薬品工業株式会社 口腔内粘膜貼付製剤
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
EP2432437A4 (de) * 2009-05-21 2012-12-19 Bionex Pharmaceuticals Llc Zwei- und einschichtige dosierformen
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
WO2011034323A2 (en) * 2009-09-16 2011-03-24 Samyang Corporation Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system
CA2795158C (en) * 2010-04-02 2019-10-22 Alltranz Inc. Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
CA2890757C (en) 2012-11-14 2021-10-26 Smith & Nephew, Inc. Stable thermolysin hydrogel
RU2015137174A (ru) 2013-03-15 2017-04-24 Смит энд Невью, Инк. Растворимая образующая гель плёнка и способ очистки раны
DK3862031T3 (da) 2013-11-08 2023-09-25 Hollister Inc Smurte, oleofile katetre
EP2889030A1 (de) * 2013-12-30 2015-07-01 Uluru Inc. Steuerung der Erosionsraten von mukoadhäsiven Vorrichtungen mit Lieferung von Wirkstoffen und anderen Verbindungen und Bereitstellung erhöhter und unterschiedlicher therapeutischer Blutwerte
JP2015232086A (ja) * 2014-06-10 2015-12-24 大日本印刷株式会社 貼付用シート
CN104436283B (zh) * 2014-11-10 2016-05-25 苏州蔻美新材料有限公司 一种医用胶原膜材料及其制备方法
WO2017085262A1 (en) * 2015-11-19 2017-05-26 Dermtreat Aps A pharmaceutical film composition having improved residence time on the application site
JP7653218B2 (ja) 2016-05-05 2025-03-28 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
WO2018092362A1 (ja) * 2016-11-18 2018-05-24 パナソニックＩｐマネジメント株式会社 生体貼付用膜およびその製造方法
WO2019069123A1 (en) 2017-10-07 2019-04-11 Zim Laboratories Ltd. METHOD FOR PREPARING A BI OR MULTILAYER FILM, MULTILAYER FILM PRODUCED THEREFROM, AND APPARATUS FOR PRODUCING SUCH MULTILAYER FILMS
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
ES2986170T3 (es) * 2019-12-20 2024-11-08 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transmucosal que contiene agomelatina
EP4076381B1 (de) * 2019-12-20 2024-12-04 LTS Lohmann Therapie-Systeme AG Transmukosales therapeutisches system mit agomelatin
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5770816A (en) * 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS60116630A (ja) * 1983-11-29 1985-06-24 Nitto Electric Ind Co Ltd 口腔内製剤
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
JPS61290423A (ja) * 1985-06-18 1986-12-20 Mitsubishi Electric Corp 液晶表示素子およびその製造方法
JPH0653659B2 (ja) * 1985-07-22 1994-07-20 ニチバン株式会社 粘膜付着製剤
JPS6256420A (ja) * 1985-09-05 1987-03-12 Teijin Ltd フイルム状付着性製剤
JPH07553B2 (ja) * 1985-12-09 1995-01-11 佐藤製薬株式会社 フイルム状製剤
JPH0729915B2 (ja) * 1986-02-01 1995-04-05 帝國製薬株式会社 シ−ト状口腔内貼付剤
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
JPH0794384B2 (ja) * 1986-09-01 1995-10-11 帝国製薬株式会社 徐放性口腔内用製剤
JPS63310818A (ja) * 1987-06-12 1988-12-19 Sato Seiyaku Kk シ−ト状口腔粘膜付着製剤
JPS6471812A (en) * 1987-09-11 1989-03-16 Sekisui Chemical Co Ltd Medical application agent
JP2635336B2 (ja) * 1987-09-30 1997-07-30 帝國製薬株式会社 徐放性口腔内用製剤
JP2685055B2 (ja) * 1988-03-08 1997-12-03 帝國製薬株式会社 シコン含有口腔粘膜貼付剤
JP2656338B2 (ja) * 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
JP2879695B2 (ja) * 1990-02-22 1999-04-05 日本曹達株式会社 口腔内粘膜付着性フィルム製剤
JP2930374B2 (ja) * 1990-06-28 1999-08-03 東亜医薬品工業株式会社 口腔内貼着型膜製剤
CN1134163A (zh) * 1993-08-19 1996-10-23 辛勒斯治疗系统公司 水溶性压敏粘膜粘合剂和配备该粘合剂用于放置在有粘膜衬里的体腔内的器具
JP2791317B2 (ja) * 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces

Also Published As

Publication number Publication date
JP2010265319A (ja) 2010-11-25
AU3967899A (en) 1999-11-16
DK1079813T3 (da) 2005-06-06
WO1999055312A3 (en) 2000-01-13
JP4619894B2 (ja) 2011-01-26
EP1079813A2 (de) 2001-03-07
DE69923675D1 (de) 2005-03-17
ES2237104T3 (es) 2005-07-16
CA2329128A1 (en) 1999-11-04
AU746339B2 (en) 2002-04-18
US20080254105A1 (en) 2008-10-16
DE69923675T2 (de) 2006-05-11
EP1079813B1 (de) 2005-02-09
JP2002512950A (ja) 2002-05-08
JP2005325140A (ja) 2005-11-24
WO1999055312A2 (en) 1999-11-04
PT1079813E (pt) 2005-05-31
CA2329128C (en) 2008-03-18

Similar Documents

Publication Publication Date Title
DE69923675D1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
MXPA04001491A (es) Dispositivo de liberacion de farmaco erosionable mucoadhesivo para la administracion controlada de compuestos activos farmaceuticos y otros compuestos activos.
NO20064395L (no) Anvendelse av buprenorfin i fremstilling av et medikament
EP0887075A3 (de) Klebstoffmasse zur transdermalen Verabreichung von stark weichmachenden Wirkstoffen
WO1998037872A3 (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
DE69531488D1 (de) Medikament enthaltende, adhesive, zusammenbaubare, transdermale abgabevorrichtung
ATE305803T1 (de) Wirkstofffreisetzung mit hilfe von therapeutischen hydrogelen
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
ATE287262T1 (de) Transdermales arzneistoffverabreichungssystem
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
IL154731A0 (en) Ion-strength independent sustained release pharmaceutical formulation
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
LV10749A (lv) Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens
DK0705085T3 (da) Molykylært transdermalt transportsystem
AR013498A1 (es) Uso de ifn-alfa y amantadine para el tratamiento de hepatitis c cronica uso de ifn-alfa
WO2002011784A3 (en) Pharmaceutical carriers and compositions for transdermal drug delivery

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1079813

Country of ref document: EP